Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jun 7;17(1):406.
doi: 10.1186/s12885-017-3365-7.

Is detection of intraperitoneal exfoliated tumor cells after surgical resection of rectal cancer a prognostic factor of survival?

Affiliations

Is detection of intraperitoneal exfoliated tumor cells after surgical resection of rectal cancer a prognostic factor of survival?

Christian Arstad et al. BMC Cancer. .

Abstract

Background: The prognostic significance of free cancer cells detected in peritoneal fluid at the time of rectal surgery remains unclear. A substantial number of patients will develop metastatic disease even with successful local treatment. This prospective non-randomized study investigated the prognostic value of intraperitoneal free cancer cells harvested in peritoneal lavage after surgery for rectal cancer. Mutational hotspots in mitochondrial DNA were examined as potential molecular signatures to detect circulating intraperitoneal free cancer cells when present in primary tumor and in lavage.

Methods: Point mutations in mitochondrial DNA amplifications were determined in primary tumors and corresponding exfoliated intraperitoneal free cancer cells in lavage from 191 patients with locally advanced rectal cancer scheduled for radical treatment. Mitochondrial DNA target sequences were amplified by polymerase chain reaction and base substitutions were detected by denaturant, cycling temperature capillary electrophoresis. Detection of intraperitoneal free cancer cells was correlated to survival.

Results: Of 191patients analyzed, 138 (72%) were identified with somatic mitochondrial point mutations in rectal cancer tumors. From this fraction, 45 patients (33%) had positive lavage fluid with corresponding somatic mtDNA point mutations in lavage representing circulating intraperitoneal free cancer cells. There was no significant survival difference between patients identified with or without somatic mitochondrial DNA point mutations in the corresponding lavage.

Conclusion: Somatic mitochondrial DNA point mutations identified in primary rectal tumors enable detection of circulating intraperitoneal free cancer cells in lavage fluid. Intraperitoneal free cancer cells harvested from lavage immediately after surgery for rectal cancer does not represent an independent prognostic factor on survival.

Keywords: Prognostic factor; Rectal cancer; Survival; mtDNA mutations.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Electropherogram of primary rectal tumor without mtDNA mutations (top) and primary rectal tumor with mtDNA mutations (lower)
Fig. 2
Fig. 2
Electropherograms of mutant positive primary rectal tumor with mtDNA mutations and in corresponding lavage A & B
Fig. 3
Fig. 3
Electropherograms of primary rectal tumor with mtDNA mutations and mtDNA mutations in lavage A, but not in lavage B
Fig. 4
Fig. 4
Electropherograms of primary rectal tumor with mtDNA mutations and without mtDNA mutations in lavage A, but with mutation in lavage B
Fig. 5
Fig. 5
Kaplan-Meier plot. Survival analysis, calculated from patients with locally advanced and locally recurrent rectal cancer, having positive IPCC or negative IPCC. No censored data
Fig. 6
Fig. 6
Kaplan-Meier plot. Survival analysis, calculated from patients with KRAS mutations positive vs. KRAS mutations negative in lavage fluid. No censored data (P = 0,177)

Similar articles

Cited by

References

    1. Cancer in Norway 2014 - Cancer incidence, mortality, survival and prevalence in Norway. Oslo:Cancer. https://www.kreftregisteret.no/globalassets/cancer-in-norway/2014/cin_20.... Registry of Norway, 2015.
    1. Valentini V, Beets-Tan R, Borras JM, Krivokapic Z, Leer JW, Pahlman L, Rodel C, Schmoll HJ, Scott N, Velde CV, et al. Evidence and research in rectal cancer. Radiother Oncol. 2008;87(3):449–474. doi: 10.1016/j.radonc.2008.05.022. - DOI - PubMed
    1. Kusters M, Marijnen CA, van de Velde CJ, Rutten HJ, Lahaye MJ, Kim JH, Beets-Tan RG, Beets GL. Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. Eur J Surg Oncol. 2010;36(5):470–476. doi: 10.1016/j.ejso.2009.11.011. - DOI - PubMed
    1. Segelman J, Granath F, Holm T, Machado M, Mahteme H, Martling A. Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer. Br. J. Surg. 2012;99(5):699–705. doi: 10.1002/bjs.8679. - DOI - PubMed
    1. Lowe E, McKenna H. Peritoneal washing cytology: a retrospective analysis of 175 gynaecological patients. Aust N Z J Obstet Gynaecol. 1989;29(1):55–61. doi: 10.1111/j.1479-828X.1989.tb02878.x. - DOI - PubMed

LinkOut - more resources